Serum [Met5]-enkephalin levels are reduced in multiple sclerosis and restored by low-dose naltrexone

Condition: Multiple sclerosis

Category: Rheumatology

Author: Michael D Ludwig

Date: Sep 2017

Type: Article

A two-part study to measure endogenous opioids in multiple sclerosis patients, and to investigate the temporal pattern of decline in serum enkephalin concentrations in mice with chronic progressive experimental autoimmune encephalomyelitis and treated with low-dose naltrexone.

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}

Not Finding What You're Looking For?

Fill out the form below to let us know.

>